Oseltamivir resistance--disabling our influenza defenses.
Moscona
Anne
A
Department of Pediatrics at Weill Medical College of Cornell University, New York, USA.
D000081:Acetamides / Q000737:chemistry / Q000600:supply & distribution / Q000627:therapeutic use*; D001665:Binding Sites; D002648:Child; D024882:Drug Resistance, Viral / Q000235:genetics; D006146:Guanidines / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy*; D009154:Mutation; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans / Q000737:chemistry / Q000627:therapeutic use; D012646:Self Administration; D012794:Sialic Acids / Q000737:chemistry / Q000627:therapeutic use; D053243:Zanamivir
D000081:Acetamides; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir